Literature DB >> 21074111

Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology.

Ruth M Pfeiffer1, William A Wheeler, Georgina Mbisa, Denise Whitby, James J Goedert, Guy de Thé, Sam M Mbulaiteye.   

Abstract

PURPOSE: Human herpesvirus 8 (HHV-8, or Kaposi sarcoma [KS]-associated herpesvirus, KSHV) is a necessary but insufficient cause of KS, as KS develops in few HHV-8-infected persons. In sub-Saharan Africa, marked differences in the geographic distribution of HHV-8 and KS suggest that environmental cofactors influence HHV-8 transmission, control, and progression to KS. However, a direct comparison of HHV-8 prevalence estimates is complicated because studies used different serologic assays and analytic methods. We assessed HHV-8 seropositivity in several African countries with heterogeneous environments and varying KS incidence using a unified approach.
METHODS: HHV-8 antibodies were measured among 3196 adults (aged 20+ years) and 2404 children (aged <20 years) from five studies in four sub-Saharan countries in Africa. Serum samples were tested by the same laboratory using K8.1 and orf73 enzyme immunoassays.
RESULTS: Children's HHV-8-seropositivity ranged from 18.1% in Kampala, Uganda, to 33.8% in North Mara, Tanzania, increasing steeply with age in all populations. Among adults, HHV-8-seropositivity ranged from 23.5% in Nigeria to 70.6% in rural West Nile, Uganda. It was higher in males and rural areas.
CONCLUSIONS: Our data indicate that geographical exposures, gender, age, and factors correlated with rural residence impact HHV-8 seropositivity in sub-Saharan Africa.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074111     DOI: 10.1016/j.annepidem.2010.07.098

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  25 in total

1.  HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.

Authors:  Sam M Mbulaiteye; Kishor Bhatia; Clement Adebamowo; Annie J Sasco
Journal:  Infect Agent Cancer       Date:  2011-10-17       Impact factor: 2.965

2.  Ultraviolet Radiation and Kaposi Sarcoma Incidence in a Nationwide US Cohort of HIV-Infected Men.

Authors:  Elizabeth K Cahoon; Eric A Engels; D Michal Freedman; Mary Norval; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

3.  Relationship between human leukocyte antigen alleles and risk of Kaposi's sarcoma in Cameroon.

Authors:  Elena M Cornejo Castro; Brian J Morrison; Vickie A Marshall; Nazzarena Labo; Wendell J Miley; Nathan Clements; George Nelson; Paul Ndom; Kristen Stolka; Jennifer J Hemingway-Foday; Mahamat Abassora; Xiaojiang Gao; Jennifer S Smith; Mary Carrington; Denise Whitby
Journal:  Genes Immun       Date:  2019-05-20       Impact factor: 2.676

4.  Human herpesvirus 8 seropositivity in rural Uganda: maturation of sero-epidemiological studies.

Authors:  Sam M Mbulaiteye; James J Goedert
Journal:  J Infect Dis       Date:  2011-01-26       Impact factor: 5.226

5.  Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.

Authors:  Kristen Stolka; Paul Ndom; Jennifer Hemingway-Foday; Jeniffer Iriondo-Perez; Wendell Miley; Nazzarena Labo; Jennifer Stella; Mahamat Abassora; Godfrey Woelk; Robin Ryder; Denise Whitby; Jennifer S Smith
Journal:  Cancer Epidemiol       Date:  2014-03-13       Impact factor: 2.984

Review 6.  A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population.

Authors:  Dorothy E Dow; Coleen K Cunningham; Ann M Buchanan
Journal:  J Pediatric Infect Dis Soc       Date:  2013-09-04       Impact factor: 3.164

7.  Classical Kaposi's Sarcoma in a Nigerian Farmer: A Case Report.

Authors:  Michael O Iroezindu; Izuchukwu B Achusi
Journal:  Eurasian J Med       Date:  2015-06

8.  Kaposi Sarcoma-Associated Herpesvirus in a Rural Ugandan Cohort, 1992-2008.

Authors:  Robert Newton; Nazzarena Labo; Katie Wakeham; Wendell Miley; Gershim Asiki; W Thomas Johnston; Denise Whitby
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

Review 9.  HIV-associated Kaposi sarcoma and related diseases.

Authors:  Priscila H Gonçalves; Thomas S Uldrick; Robert Yarchoan
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

10.  Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011).

Authors:  Lia Koski; Twalib Ngoma; Julius Mwaiselage; Lynne Le; Amr S Soliman
Journal:  Int J STD AIDS       Date:  2014-07-30       Impact factor: 1.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.